Should I Buy OMCL? OMCL 2026 Analysis

Should You Buy Omnicell Inc (OMCL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

37.070

1 Day change

-5.14%

52 Week Range

55.000

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient entry: the stock is in a sharp post-earnings selloff (-16%+) with momentum still deteriorating (MACD negative and expanding).
While oversold conditions (RSI_6 ~10) can create a bounce, options flow is bearish/defensive (put volume > call volume) and insiders have been net sellers, reducing the odds of an immediate sustained rebound.
Intellectia Proprietary Trading Signals
- AI Stock Picker: No signal on given stock today.
- SwingMax: No signal on given stock recently.
Best stance today: Hold/Avoid new buys until price stabilizes above nearby resistance (around the pivot zone) or momentum turns; this avoids “catching the falling knife” after the earnings gap-down.

Technical Analysis

Price action: steep breakdown today (regular market -16.41%; pre-market -16.73%), indicating a strong risk-off reaction to earnings.
Momentum: MACD histogram -1.254 (below 0) and negatively expanding → downtrend pressure still increasing.
RSI: RSI_6 at 10.319 → extremely oversold, which can produce short bounces, but oversold can persist during selloffs.
Moving averages: “converging” suggests a transition zone, but today’s gap-down likely reasserts bearish control.
Key levels:
- Resistance/pivot: 45.337 (regaining this would signal meaningful stabilization)
- Near-term resistance: 50.698 (R1)
- Support: 39.975 (S1) is essentially being tested/failed with price ~38.97
- Next support: 36.663 (S2) is the next downside level to watch
Pattern-based forward odds (provided): ~80% chance of +3.34% next day (possible dead-cat bounce), but still negative bias for next week (-3.61%) and next month (-1.38%).

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Sentiment read-through:
- Open interest P/C = 0.77: positioning slightly call-leaning on OI (not panic-hedged on outstanding contracts).
- Volume P/C = 1.43: today’s trading flow is put-heavy, consistent with near-term bearishness / hedging after the drop.
Volatility:
- Implied vol (30d) 61.12 vs historical vol 34.13 → options are pricing elevated event/uncertainty.
- IV percentile 94.82 → IV is extremely high relative to its own history, typical after earnings gaps.
Activity:
- Today’s option volume vs 30d avg: 227.66% → unusually high attention/positioning today.
Takeaway: options market is pricing high uncertainty and near-term demand for puts—this argues against “easy” immediate upside despite oversold technicals.

Technical Summary

Sell

Buy

Positive Catalysts

- Product cycle optimism: Titan XT launch is being framed by analysts as the first major new cabinet since 2017 and potentially the start of a multi-year replacement/upgrade cycle.
- Analyst support strengthened materially: multiple firms reiterating/raising targets recently; BofA just upgraded to Buy with a high target.
- Revenue resilience: Q4 revenue slightly beat expectations; FY2025 total revenue reported up ~7% YoY to $1.185B.
- Potential for reflex bounce: extremely oversold RSI and heavy post-earnings capitulation can produce short-term rebounds.

Neutral/Negative Catalysts

- Earnings disappointment: Q4 non-GAAP EPS 0.40 missed 0.50 estimate (a notable miss that likely drove the gap-down).
- Trend/momentum is still bearish: MACD is negative and worsening; price is below/around key support (S1 ~39.98).
- Options flow today is defensive/bearish: put volume outpacing calls (volume P/C 1.43).
- Insider behavior: insiders are selling, with selling amount increased 151.38% over the last month.
- Profitability pressure in recent quarters: prior snapshot showed net income/EPS down sharply YoY and slight gross margin compression.

Financial Performance

Latest reported event (QDEC 2025 / Q4 2025 earnings, reported 2026-02-05 pre-market):
- Non-GAAP EPS: 0.40 vs 0.50 est (miss)
- Revenue: $314M slightly above expectations
- FY2025 revenue: $1.185B, +7% YoY (growth, but earnings quality is the concern)
Prior quarter snapshot (2025/Q3):
- Revenue: $310.631M, +9.99% YoY (solid top-line growth)
- Net income: $5.462M, -36.71% YoY
- EPS: $0.12, -36.84% YoY
- Gross margin: 43.3%, -0.51% YoY
Bottom line: revenue growth is holding up, but profitability has been trending weaker, which increases sensitivity to any execution hiccups.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: a clear upward revision cycle in ratings/targets into earnings driven by the Titan XT “super-cycle” thesis.
Key changes:
- 2026-02-04: BofA upgraded to Buy from Neutral; PT raised to $70 (from $53).
- 2026-02-02: Benchmark reiterated Buy; PT raised to $60 (from $50).
- 2026-01-07/08: KeyBanc upgraded to Overweight; PT $60.
- 2026-01-05: Wells Fargo maintained Overweight; PT $52; added to Tactical Ideas list.
Wall Street “pros” view:
- Pros: Titan XT and cabinet refresh could drive multi-year bookings/revenue acceleration; potential competitive wins in a duopoly.
- Cons: near-term earnings/margin execution risk is real (latest EPS miss + prior profitability declines), and today’s price action suggests the market is prioritizing near-term fundamentals over the longer-cycle story.
Influential/political trading:
- Congress: No recent congress trading data available.
- Politicians/other influential figures: none provided in the data.

OMCL Should I Buy